Trivalent ganglioside vaccine and immunologic adjuvant versus adjuvant alone in metastatic sarcoma patients rendered disease-free by surgery: A randomized phase 2 trial.
Richard D. Carvajal
Research Funding - MabVax
Mark Agulnik
Research Funding - MabVax
Christopher W. Ryan
Research Funding - MabVax
Mohammed M. Milhem
Research Funding - MabVax
Suzanne George
Research Funding - MabVax
Robin Lewis Jones
Research Funding - MabVax
Bartosz Chmielowski
Research Funding - MabVax
Brian Andrew Van Tine
Research Funding - MabVax
Hussein Abdul-Hassan Tawbi
Research Funding - MabVax
Anthony D. Elias
Research Funding - MabVax
William L. Read
Research Funding - MabVax
G. Thomas Budd
Research Funding - MabVax
Joe Hirman
Consultant or Advisory Role - MabVax
Paul Weiden
Consultant or Advisory Role - MabVax
Cathryn M. Bennett
Employment or Leadership Position - MabVax
Philip O. Livingston
Employment or Leadership Position - MabVax
David Hansen
Employment or Leadership Position - MabVax
Robert G. Maki
No relevant relationships to disclose
Gary K. Schwartz
Research Funding - MabVax
Rashmi Chugh
Research Funding - MabVax